Register for free today to discover the latest science and technology advancements in coronavirus research, CAR T-cell therapy, genomics, liquid biopsies, imaging, drug delivery mechanisms, microbiome research and more
Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes
To be in with a chance of winning a $500 Amazon voucher, simply cast your vote for the product that has made the most difference to your research
The research-grade PepTivator Peptide Pools are designed to stimulate SARS-CoV-2 T-cells
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development
Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020
Differentiate human pluripotent stem cells to muscle myotubes
Don’t miss this webinar to find out how single-cell transcriptional profiling is overcoming the issue of undefined cell populations
Visit booth 3624 to meet the team, pick up a free T-shirt and join in the musical fun as popular singer Alexander Joseph returns with his grand piano
Transaction adds comprehensive cell editing capabilities and engine to support expansion of Abcam’s existing portfolio of ‘off-the-shelf’ edited cell lines
Researchers use 3D cell culture to uncover the link between vitamin D deficiency and intestinal stem cells
Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29
This collaboration promises to develop stem cell therapies for life-threatening diseases
Sechenov University and the University College Cork have developed a method for studying mitochondrial polarization in live cells and tissues
AMSBIO is advancing stem cell discovery with the GenePORTER 2 reagent for transfection
AMSBIO has introduced human recombinant iMatrix Laminin 211 fragments as a high-quality matrix for basic research, drug development and toxicity studies
AMSBIO has found a reagent to best transfect its human embryonic stem cells
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
Options to vacuum filter smaller volumes of 50mL at high speeds resolve time-consuming steps in cell line development
Researcher Meritxell Huch awarded the BINDER Innovation Prize
The eCHO™ Medium is ideal for the manufacture of recombinant proteins for medical use, including monoclonal antibodies and complex glycoproteins
